These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20939015)

  • 21. Perspectives of quality care in cancer treatment: a review of the literature.
    Hess LM; Pohl G
    Am Health Drug Benefits; 2013 Jul; 6(6):321-9. PubMed ID: 24991367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
    Jones G; Hughes J; Mahmoodi N; Smith E; Skull J; Ledger W
    Hum Reprod Update; 2017 Jul; 23(4):433-457. PubMed ID: 28510760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The perfect storm: managed care, aging adults, and a nursing shortage.
    Curtin LL
    Nurs Adm Q; 2007; 31(2):105-14. PubMed ID: 17413502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example.
    Jackisch C; Manevy F; Frank S; Roberts N; Shafrin J
    Adv Ther; 2022 Feb; 39(2):833-844. PubMed ID: 34988876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
    Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
    Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for individualizing management of patients with metastatic melanoma: a managed care perspective.
    Goldstein DA; Zeichner SB
    Am J Manag Care; 2015 Sep; 21(10 Suppl):S234-41. PubMed ID: 26619297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Willingness to accept chemotherapy and attitudes towards costs of cancer treatment; A multisite survey study in the Netherlands.
    van Dijk EF; Coşkuntürk M; Zuur AT; van der Palen J; van der Graaf WT; Timmer-Bonte JN; Wymenga AN
    Neth J Med; 2016 Aug; 74(7):292-300. PubMed ID: 27571944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.
    Matsuyama R; Reddy S; Smith TJ
    J Clin Oncol; 2006 Jul; 24(21):3490-6. PubMed ID: 16849766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States.
    Brogan AP; Hogue SL; Vekaria RM; Reynolds I; Coukell A
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1319-1327. PubMed ID: 31778613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].
    Jaussent S; Labarère J; Boyer JP; François P
    Encephale; 2004; 30(5):437-46. PubMed ID: 15627048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How communication between cancer patients and their specialists affect the quality and cost of cancer care.
    Slavova-Azmanova N; Newton JC; Hohnen H; Johnson CE; Saunders C
    Support Care Cancer; 2019 Dec; 27(12):4575-4585. PubMed ID: 30927112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution, growth, and status of managed care in the United States.
    Block LE
    Public Health Rev; 1997; 25(3-4):193-244. PubMed ID: 9553445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managed care & medical oncology: the focus is on value.
    Danielson E; Demartino J; Mullen JA
    J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managed care contracting for specialists.
    Alexander JM
    Healthc Financ Manage; 1999; Suppl():6-10. PubMed ID: 10338936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.